Re­call re­port: Zy­dus re­calls her­pes drug af­ter crys­tal­liza­tion com­plaints; Alem­bic pulls low blood pres­sure drug for in­cor­rect la­bel­ing

It’s been a rel­a­tive­ly qui­et start to the year in terms of drug re­calls, but the FDA hit two gener­ics mak­ers late last week for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.